Your browser doesn't support javascript.
loading
Weekly Cyclophosphamide-Bortezomib-Dexamethasone Induction Performs Comparably to Twice-Weekly Dosing with Respect to Both Response Rates and Survival after Autologous Transplant.
Thirunavukarasu, Caitlin; Weber, Nicholas; Morris, Kirk; Subramonia Pillai, Elango; Curley, Cameron; Butler, Jason; Kennedy, Glen.
Afiliação
  • Thirunavukarasu C; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia, caitlin.thiru@health.qld.gov.au.
  • Weber N; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Morris K; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Subramonia Pillai E; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Curley C; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Butler J; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Kennedy G; Department of Haematology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Acta Haematol ; 143(3): 295-296, 2020.
Article em En | MEDLINE | ID: mdl-31689702

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Acta Haematol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Acta Haematol Ano de publicação: 2020 Tipo de documento: Article